Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Apple
AAPL
|
$9.29B |
| 2 |
NVIDIA
NVDA
|
$1.77B |
| 3 |
Broadcom
AVGO
|
$1.59B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$1.52B |
| 5 |
T-Mobile US
TMUS
|
$1.48B |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$3.16B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$2.92B |
| 3 |
Amazon
AMZN
|
$2.22B |
| 4 |
Microsoft
MSFT
|
$2.14B |
| 5 |
Merck
MRK
|
$1.72B |
Sector Composition
| 1 | Technology | 24.16% |
| 2 | Healthcare | 19.43% |
| 3 | Financials | 13.51% |
| 4 | Consumer Discretionary | 9.13% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
HF Sinclair
DINO
$9.65B
| $585K | ﹤0.01% |
10,975
+806
| +8% | +$43K |
|
1652
Avita Medical
RCEL
$116M
| $580K | ﹤0.01% |
73,207
+7,794
| +12% | +$61.7K |
|
1653
Roku
ROKU
$14.3B
| $575K | ﹤0.01% |
9,587
+5,267
| +122% | +$316K |
|
1654
BioMarin Pharmaceuticals
BMRN
$10.9B
| $569K | ﹤0.01% |
6,917
+597
| +9% | +$49.2K |
|
1655
Charles River Laboratories
CRL
$7.99B
| $568K | ﹤0.01% |
2,750
+227
| +9% | +$46.9K |
|
1656
MSC Industrial Direct
MSM
$5.16B
| $560K | ﹤0.01% |
7,064
-2,611
| -27% | -$207K |
|
1657
MindMed
MNMD
$702M
| $552K | ﹤0.01% |
76,570
+21,505
| +39% | +$155K |
|
|
WRK
1658
DELISTED
WestRock Company
WRK
| $542K | ﹤0.01% |
10,786
-54,705
| -84% | -$2.75M |
|
|
CTLT
1659
DELISTED
CATALENT, INC.
CTLT
| $538K | ﹤0.01% |
9,575
+797
| +9% | +$44.8K |
|
1660
Lyell Immunopharma
LYEL
$225M
| $533K | ﹤0.01% |
+18,384
| New | +$533K |
|
1661
Biomea Fusion
BMEA
$109M
| $533K | ﹤0.01% |
118,463
+15,929
| +16% | +$71.7K |
|
1662
TScan Therapeutics
TCRX
$107M
| $532K | ﹤0.01% |
+90,941
| New | +$532K |
|
1663
Snap
SNAP
$12B
| $523K | ﹤0.01% |
31,487
+18,917
| +150% | +$314K |
|
1664
NNN REIT
NNN
$8B
| $514K | ﹤0.01% |
12,067
-5,899
| -33% | -$251K |
|
1665
Arrow Electronics
ARW
$6.53B
| $503K | ﹤0.01% |
4,162
-2,679
| -39% | -$324K |
|
1666
Premier
PINC
$2.17B
| $492K | ﹤0.01% |
26,332
-206,062
| -89% | -$3.85M |
|
1667
Tourmaline Bio
TRML
$645M
| $489K | ﹤0.01% |
38,034
+13,089
| +52% | +$168K |
|
1668
Arcutis Biotherapeutics
ARQT
$1.94B
| $486K | ﹤0.01% |
52,226
+5,679
| +12% | +$52.8K |
|
|
NBIS
1669
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.5B
| $477K | ﹤0.01% |
50,402
| – | – |
|
|
IGMS
1670
DELISTED
IGM Biosciences
IGMS
| $474K | ﹤0.01% |
68,965
+11,775
| +21% | +$80.9K |
|
1671
Relay Therapeutics
RLAY
$690M
| $469K | ﹤0.01% |
71,913
+18,499
| +35% | +$121K |
|
1672
Inhibrx
INBX
$402M
| $449K | ﹤0.01% |
+31,678
| New | +$449K |
|
1673
Henry Schein
HSIC
$8.22B
| $445K | ﹤0.01% |
6,937
-23,483
| -77% | -$1.51M |
|
1674
Elastic
ESTC
$9B
| $436K | ﹤0.01% |
3,829
-3,605
| -48% | -$411K |
|
1675
Reddit
RDDT
$43.4B
| $436K | ﹤0.01% |
6,826
-82,370
| -92% | -$5.26M |
|